We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Handheld Fluorescent Immunoassay Analyzer for Rapid POC Testing to Transform Clinical Diagnostics

By LabMedica International staff writers
Posted on 17 Jul 2023
Print article
Image: The AF-100S automated, compact, and affordable fluorescent Immunoassay (FIA) solution (Photo courtesy of Anbio)
Image: The AF-100S automated, compact, and affordable fluorescent Immunoassay (FIA) solution (Photo courtesy of Anbio)

An automated, compact, and affordable fluorescent Immunoassay (FIA) solution is designed to transform the landscape of clinical point-of-care (POC) diagnostics.

Anbio Biotechnology (Frankfurt, Germany) has launched the new AF-100S FIA Solution, a compact, handheld solution for point-of-care immunodiagnostic needs that delivers rapid, accurate, and reliable results. The innovative analyzer is capable of detecting a broad spectrum of analytes, such as hormones, enzymes, and infectious diseases, making it a versatile diagnostic tool. Its compact design, lasting battery life, and user-friendly interface make it a practical choice for diverse environments. Its high sensitivity and specificity guarantee that patients are provided accurate results.

The AF-100S employs fluorescently labeled antibodies or antigens to identify specific biomolecules in a patient's sample. When a sample is combined with these labeled antibodies or antigens, the biomolecule, if present, binds to these labeled molecules, creating a complex that releases a fluorescent signal. This signal is then measured and compared with a recognized standard to ascertain the biomolecule's concentration in the sample.

This small yet efficient FIA analyzer can perform up to 240 tests per hour, making it a good fit for high-volume settings. It is powered by a lithium battery that supports up to 800 tests per charge or offers 20 days of device standby time. Its user-friendly interface, shown on a large color touchscreen, simplifies operation. The compact size of the AF-100S, measuring just 195x100x70mm, makes it an optimal choice for various medical settings such as private clinics, urgent care centers, emergency departments, and ambulances.

"The Anbio AF-100S is set to transform the field of clinical diagnostics, empowering healthcare providers with a cost-effective and comprehensive solution," said Sa Jiang, Chief Marketing Officer at Anbio. "Our FIA solution is small, yet powerful point-of-care immunodiagnostic solution that provides rapid, accurate, and reliable results for a wide range of analytes to provide faster diagnosis and better prognosis to patients."

Related Links:
Anbio Biotechnology

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Hemoglobin Testing System
VARIANTnbs

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The HelioLiver Dx test has met the coprimary and secondary study endpoints in the CLiMB trial (Photo courtesy of Helio Genomics)

Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection

Patients with liver cirrhosis and chronic hepatitis B are at a higher risk for developing hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. The American Association for the Study... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The POC PCR test shortens time for STI test results (Photo courtesy of Visby Medical)

POC STI Test Shortens Time from ED Arrival to Test Results

In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.